Condition
H Pylori
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 4 (2)
Trial Status
Not Yet Recruiting3
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07537634Phase 4Recruiting
Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication
NCT06632210Not Yet RecruitingPrimary
Psychological Effects of H Pylori Associated Gastritis
NCT07157202Not Yet RecruitingPrimary
Associating Gastric Infection With Autoimmune Flare Severity in an Egyptians
NCT07040839Phase 4Not Yet RecruitingPrimary
Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection
Showing all 4 trials